Orphan Drug Status Goes to Engineered T-Cell Product

The U.S. Food & Drug Administration has awarded Orphan Drug Status to Kite Pharma for the company's engineered T-cell product.

Kite Pharma's engineered T-cell product is designed to treat difficult-to-treat cases of diffuse large B-cell lymphoma. This is an autologous T-cell, meaning it is contributed by the patient and then engineered in a laboratory before being returned to the patient.

Company aims for 'Holy Grail' of cancer treatment

In this case, Kite Pharma's engineering teaches the T-cells to target CD19 protein expression on the surface of B-cell lymphocytes and to kill them, effectively enlisting the body's own immune system to fight cancer – a goal considered by many to be the Holy Grail of cancer treatment.

Kite Pharma was launched five years ago, in 2009. They have been part of a cooperative research and development agreement with the National Cancer Institute's surgery branch to develop this Chimeric Antigen Receptor CD19 technology.

A pair of studies presented at the ASH conference in December showed the potential efficacy of the treatment in a handful of DLBCL patients.

Source: Healio

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...